Answers are grounded in this paper and cite their sources.
Preclinical evaluation demonstrates sustained normoglycemia in diabetic animal models, indicating therapeutic viability of microencapsulated porcine islets.
To provide a plentiful supply of pancreatic islets for future clinical transplants into diabetic patients, the authors have developed a simple and consistent method of isolation of porcine islets. Both in vitro and in vivo studies demonstrated that the islets were viable and functional. Xenotransplants of 1.5 x 10(3) - 2.5 x 10(3) of microencapsulated porcine islets into diabetic mice resulted in restoration of normoglycemia in 13 of 18 experimental animals for up to 10 months. A xenograft of 50 x 10(3) microencapsulated porcine islets into a spontaneously diabetic monkey normalized hyperglycemia for more than 150 days. This experiment indicated that the transplantation of encapsulated porcine islets has great potential as a clinical treatment in diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Sun et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: